J Stroke.  2022 May;24(2):303-306. 10.5853/jos.2022.00836.

Association of Symptomatic Hearing Loss with Functional and Cognitive Recovery 1 Year after Intracerebral Hemorrhage

Affiliations
  • 1Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
  • 2Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
  • 3Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
  • 4Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA


Figure

  • Figure 1. Functional and cognitive recovery following intracerebral hemorrhage (ICH) among survivors with and without hearing loss. (A) Comparison of distribution in modified Rankin Scale (mRS) scores at 3 months vs. 12 months among ICH survivors without (top bars) vs. with (bottom bars) hearing loss. Numbers in the bar section refer to count of individuals within each subgroup defined by mRS scores. (B) Comparison of distribution in cognitive status diagnoses at 3 months vs. 12 months among ICH survivors without (top bars) vs. with (bottom bars) hearing loss. Numbers in the bar section refer to count of individuals within each subgroup defined by diagnosis of major neurocognitive disorder (NCD), minor NCD, or normal cognition at each time point.


Reference

References

1. Pasi M, Sugita L, Xiong L, Charidimou A, Boulouis G, Pongpitakmetha T, et al. Association of cerebral small vessel disease and cognitive decline after intracerebral hemorrhage. Neurology. 2021; 96:e182–e192.
Article
2. Biffi A, Bailey D, Anderson CD, Ayres AM, Gurol EM, Greenberg SM, et al. Risk factors associated with early vs delayed dementia after intracerebral hemorrhage. JAMA Neurol. 2016; 73:969–976.
Article
3. Benedictus MR, Hochart A, Rossi C, Boulouis G, Hénon H, van der Flier WM, et al. Prognostic factors for cognitive decline after intracerebral hemorrhage. Stroke. 2015; 46:2773–2778.
Article
4. Vaisbuch Y, Santa Maria PL. Age-related hearing loss: innovations in hearing augmentation. Otolaryngol Clin North Am. 2018; 51:705–723.
5. Biffi A, Anderson CD, Battey TW, Ayres AM, Greenberg SM, Viswanathan A, et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA. 2015; 314:904–912.
Article
6. Biffi A, Murphy MP, Kubiszewski P, Kourkoulis C, Schwab K, Gurol ME, et al. APOE genotype, hypertension severity and outcomes after intracerebral haemorrhage. Brain Commun. 2019; 1:fcz018.
Article
7. Janssen PM, Visser NA, Dorhout Mees SM, Klijn CJ, Algra A, Rinkel GJ. Comparison of telephone and face-to-face assessment of the modified Rankin Scale. Cerebrovasc Dis. 2010; 29:137–139.
Article
8. Murphy MP, Kuramatsu JB, Leasure A, Falcone GJ, Kamel H, Sansing LH, et al. Cardioembolic stroke risk and recovery after anticoagulation-related intracerebral hemorrhage. Stroke. 2018; 49:2652–2658.
Article
9. Johnson JC, Marshall CR, Weil RS, Bamiou DE, Hardy CJ, Warren JD. Hearing and dementia: from ears to brain. Brain. 2021; 144:391–401.
Article
Full Text Links
  • JOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr